VAPING CESSATION

Clinical trials for VAPING CESSATION explained in plain language.

Never miss a new study

Get alerted when new VAPING CESSATION trials appear

Sign up with your email to follow new studies for VAPING CESSATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Vaping breakthrough? drug trial aims to help millions quit for good

Disease control Not yet recruiting

This phase 3 trial tests whether a drug called cytisinicline, taken three times daily for 12 weeks along with behavioral support, can help adults stop using nicotine e-cigarettes. About 800 daily vapers will be randomly assigned to receive either the drug or a placebo. The main g…

Matched conditions: VAPING CESSATION

Phase: PHASE3 • Sponsor: Achieve Life Sciences • Aim: Disease control

Last updated Jun 10, 2026 13:27 UTC

VAPING CESSATION

Get alerted when new VAPING CESSATION trials appear

Vaping breakthrough? drug trial aims to help millions quit for good